Cargando…

COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance

Detalles Bibliográficos
Autores principales:	Cannegieter, Suzanne C., Klok, Frederikus A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264646/ https://www.ncbi.nlm.nih.gov/pubmed/32542209 http://dx.doi.org/10.1002/rth2.12350

Ejemplares similares

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
por: Thachil, Jecko, et al.
Publicado: (2020)

RE: ISTH interim guidance to recognition and management of coagulopathy in COVID‐19
por: Akima, Satoshi, et al.
Publicado: (2020)

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A comment
por: Barrett, Christopher D., et al.
Publicado: (2020)

Estimating incidence of venous thromboembolism in COVID‐19: Methodological considerations
por: Nab, Linda, et al.
Publicado: (2022)

Commentary on “Risk of venous thromboembolism after COVID‐19 vaccination”
por: Frere, Corinne, et al.
Publicado: (2022)

Commentary: The evolution of extracorporeal membrane oxygenation for COVID-19: Through the eyes of the experts
por: Pagani, Francis D.
Publicado: (2023)

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
por: Barnes, Geoffrey D., et al.
Publicado: (2020)

Tumor‐expressed microRNAs associated with venous thromboembolism in colorectal cancer
por: Anijs, Rayna J. S., et al.
Publicado: (2022)

Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy
por: Elbeddini, Ali, et al.
Publicado: (2020)

Pulmonary Thromboembolism as a Potential Cause of Clinical Deterioration in COVID-19 Patients; a Commentary
por: Safari, Saeed, et al.
Publicado: (2020)

COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU
por: Zheng, Runhui, et al.
Publicado: (2021)

Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism
por: van der Wall, Sake J., et al.
Publicado: (2018)

Anticoagulation in splanchnic and cerebral vein thrombosis: Still groping in the dark
por: Klok, Frederikus A., et al.
Publicado: (2020)

Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia
por: Costanzo, Luca, et al.
Publicado: (2020)

First do no harm
por: Huisman, Menno V., et al.
Publicado: (2022)

Commentary: Another tool for the chronic thromboembolic pulmonary hypertension toolbox
por: Chan, Justin C.Y., et al.
Publicado: (2022)

Commentary on the 2023 ASH guidelines for thrombophilia testing in venous thromboembolism
por: Juneja, Manu, et al.
Publicado: (2023)

Interim Guidance for Urodynamic Practice during COVID-19 Pandemic
por: Figueiredo, André Avarese, et al.
Publicado: (2020)

Changes in incidence of hospitalization for cardiovascular diseases during the COVID-19 pandemic in The Netherlands in 2020
por: Kempers, Eva K., et al.
Publicado: (2023)

COVID-19, coagulopathy and venous thromboembolism: more questions than answers
por: Marietta, Marco, et al.
Publicado: (2020)

COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
por: Roncati, Luca, et al.
Publicado: (2020)

Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and Commentary
por: Au, Ka Loong Kelvin, et al.
Publicado: (2020)

Commentary: The Ross reversal: A rare operation to be done by experts only
por: Bacha, Emile
Publicado: (2021)

Pulmonary thromboembolic events in COVID‐19—A systematic literature review
por: Overton, Paul M., et al.
Publicado: (2022)

Commentary: Turkish blacksmiths were expert craftsmen at manufacturing scimitars; congenital cardiac surgeons need to be expert craftsmen at repairing them
por: Kalfa, David
Publicado: (2020)

Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
por: Fazili, Masarret, et al.
Publicado: (2019)

COVID-19, coagulopathy and venous thromboembolism: more questions than answers—comment
por: Ponzetto, Antonio, et al.
Publicado: (2020)

Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review
por: Yousefi, Parastoo, et al.
Publicado: (2023)

Commentary: COVID-19-associated mucormycosis: The ongoing battle
por: Nair, Akshay Gopinathan
Publicado: (2021)

Commentary: COVID-19 and diabetes
por: Villabona, Carmen V.
Publicado: (2020)

Hemostatic resuscitation for acute traumatic coagulopathy
por: Scalea, Thomas M
Publicado: (2011)

Guidance for nebulization during the COVID-19 pandemic
por: Swarnakar, Rajesh, et al.
Publicado: (2021)

Commentary: Training in the time of coronavirus disease 2019 (COVID-19)
por: Tibayan, Frederick A.
Publicado: (2021)

Commentary: Obesity in the time of coronavirus disease 2019 (COVID-19)
por: Shah, Ashish S.
Publicado: (2021)

Commentary: Combating COVID-19-associated mucormycosis with limited resources
por: Kim, Usha, et al.
Publicado: (2022)

Hot Topic Commentary on COVID-19
por: Kong, Ah-Ng, et al.
Publicado: (2020)

Is fibrinogen the answer to coagulopathy after massive transfusions?
por: Tisherman, Samuel A
Publicado: (2010)

Pulmonary Thromboembolism in COVID-19
por: Woodard, Pamela K.
Publicado: (2020)

British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance
por: Churchhouse, Antonia MD, et al.
Publicado: (2023)

Assisted reproduction and thromboembolic risk in the COVID-19 pandemic
por: Fabregues, Francesc, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ig8c046bqfqtfdkv3s93r2lh4p